$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
舒尼替尼治疗卵巢癌具有一定疗效
2025-10-19 11:44:20
Check Details
尼拉帕尼获批治疗卵巢癌
2025-10-19 11:44:20
Check Details
尼拉帕尼治疗卵巢癌疗效如何?
2025-10-19 11:44:20
Check Details
卵巢癌二线治疗推荐用药:奥拉帕尼
2025-10-19 11:44:20
Check Details
奥拉帕尼延长卵巢癌的患者生存期
2025-10-19 11:44:20
Check Details
服用奥拉帕尼多久会产生耐药?
2025-10-19 11:44:20
Check Details
卵巢癌治疗靶向药之奥拉帕尼
2025-10-19 11:44:20
Check Details
卵巢癌治疗靶向药之尼拉帕尼
2025-10-19 11:44:20
Check Details
尼拉帕尼治疗复发性卵巢癌的疗效
2025-10-19 11:44:20
Check Details
奥拉帕尼用于卵巢癌患者维持疗法
2025-10-19 11:44:20
Check Details
卵巢癌患者服用奥拉帕尼之前的基因检测结果有哪些呢?
2025-10-19 11:44:20
Check Details
卵巢癌治疗靶向药的重大突破之尼拉帕尼
2025-10-19 11:44:20
Check Details
1
2
...
763
764
765
766
767
768
769
...
4151
4152
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Fulvestrant (Faslodex) Breast Cancer Guide: Indications, Dosage and Safety Specifications
2
Adagrasib (Krazati): Full Guide to KRAS G12C Inhibitor for Cancer Treatment
3
Comprehensive Analysis of the Third-Generation EGFR-TKI
4
ATOMIC Study: Atezolizumab Plus Chemo Improves DFS in dMMR Stage III Colon Cancer
5
Oncology Immunotherapy vs Anti-Inflammatory Biologic: Dostarlimab vs Secukinumab - A Mechanism-Centered Comparison
6
Third-Generation TKI Redefining Treatment for ALK+ & ROS1+ NSCLC
7
Brigatinib Medication Case Study: Three-Year Treatment Record and Experience Sharing of ALK-Positive Lung Cancer Patient
8
What is Brigatinib (Alunbrig)? Complete Guide to ALK-Positive Lung Cancer Targeted Therapy & Medication Guidelines
9
Repotrectinib (Augtyro) Complete Medication Guide 2026: Import Original Drug Price, Eligible Patients & Full Usage Information
10
Ceritinib Capsule Storage Conditions & Expiration Guide: Room Temperature Storage, No Refrigeration Needed
11
Selumetinib for NF1 Treatment: Complete Guide to Targeted Therapy for Type 1 Neurofibromatosis
12
Alectinib for ALK-Positive Lung Cancer: Efficacy, Side Effects & Clinical Outlook